BlackRock Health Sciences Term Trust (NYSE:BMEZ) Major Shareholder Saba Capital Management, L.P. Purchases 29,795 Shares of Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. acquired 29,795 shares of the firm’s stock in a transaction dated Wednesday, October 16th. The shares were purchased at an average price of 15.81 per share, for a total transaction of 471,058.95. Following the completion of the transaction, the insider now directly owns 20,750,913 shares in the company, valued at approximately 328,071,934.53. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Monday, October 14th, Saba Capital Management, L.P. purchased 15,281 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 15.87 per share, with a total value of 242,509.47.
• On Monday, September 30th, Saba Capital Management, L.P. acquired 8,012 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average price of 15.84 per share, for a total transaction of 126,910.08.
• On Friday, September 27th, Saba Capital Management, L.P. bought 1,633 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average price of 15.89 per share, with a total value of 25,948.37.
• On Wednesday, September 25th, Saba Capital Management, L.P. purchased 300 shares of BlackRock Health Sciences Term Trust stock. The stock was acquired at an average cost of 15.73 per share, for a total transaction of 4,719.00.
• On Monday, September 23rd, Saba Capital Management, L.P. acquired 2,006 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.98 per share, with a total value of 32,055.88.
• On Thursday, September 19th, Saba Capital Management, L.P. bought 15,455 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average cost of 16.14 per share, for a total transaction of 249,443.70.
• On Tuesday, September 17th, Saba Capital Management, L.P. bought 27,148 shares of BlackRock Health Sciences Term Trust stock. The shares were bought at an average cost of 15.93 per share, with a total value of 432,467.64.

BlackRock Health Sciences Term Trust Trading Down 1.1 %

Shares of NYSE BMEZ opened at 15.67 on Friday. The firm’s fifty day moving average is 15.87 and its two-hundred day moving average is 15.50. BlackRock Health Sciences Term Trust has a 52-week low of 12.93 and a 52-week high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be given a $0.176 dividend. The ex-dividend date is Tuesday, October 15th. This represents a $2.11 dividend on an annualized basis and a dividend yield of 13.48%.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. increased its stake in BlackRock Health Sciences Term Trust by 21.7% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock worth $96,000 after acquiring an additional 1,038 shares during the last quarter. Register Financial Advisors LLC grew its holdings in shares of BlackRock Health Sciences Term Trust by 5,365.6% in the second quarter. Register Financial Advisors LLC now owns 6,832 shares of the company’s stock valued at $105,000 after purchasing an additional 6,707 shares in the last quarter. Shaker Financial Services LLC purchased a new position in shares of BlackRock Health Sciences Term Trust in the second quarter valued at $184,000. Comerica Bank increased its position in BlackRock Health Sciences Term Trust by 31.1% in the first quarter. Comerica Bank now owns 15,469 shares of the company’s stock worth $254,000 after purchasing an additional 3,671 shares during the last quarter. Finally, Dakota Wealth Management raised its stake in BlackRock Health Sciences Term Trust by 5.3% during the second quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock valued at $280,000 after purchasing an additional 915 shares in the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.